V419 (PR51)

· MCM Vaccines B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V419 (PR51), covering 2019-03-28 to 2019-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) [Phase 3]